Latest filing published 14 Jul 2026 for XOMA Royalty Corp. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
This profile gathers the share dealings of Owen Hughes across 4 companies, led by XOMA Royalty Corp, Pardes Biosciences, Inc. and Radius Health, Inc. Over a trading history stretching from 14 September 2021 to 14 July 2026, the count stands at 17 filings.
Market trades split into 4 purchases (€2.2M) and 1 sale. No amount is published for 1 filing, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 2 share grants and 4 option exercises.
In size, the median ticket on the buying side is €8,764. On 2 out of 4 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
On 14 July 2026 came the latest disclosure, a transaction in XOMA Royalty Corp. The most recent open-market purchase was published on 8 December 2025, 314 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
17 of 17 declarations